Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Declan G Murphy

Showing results (321-330 of 415) with videos related to

Pageof 42
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in the proPSMA StudyDavid C Chen, James P Buteau, Louise Emmett, et al.
The Medical Journal of Australia|June 4, 2013
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011Sue M Evans, Jeremy L Millar, Ian D Davis, et al.
BJU International|June 28, 2025
Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinomaMuhammad Ali, Mathias Bressel, David Chang, et al.
The International Journal of Neuropsychopharmacology|October 12, 2017
Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal SymptomsGemma Modinos, Fatma Simsek, Jamie Horder, et al.
European Urology|September 20, 2018
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical TrialShankar Siva, Mathias Bressel, Declan G Murphy, et al.
Social Cognitive and Affective Neuroscience|December 31, 2015
Heritability of the limbic networksSanja Budisavljevic, Jamie M Kawadler, Flavio Dell'Acqua, et al.
BJU International|March 8, 2021
UpFrontPSMA: a randomized phase 2 study of sequential <sup>177</sup> Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naïve prostate cancer (clinical trial protocol)Nattakorn Dhiantravan, Louise Emmett, Anthony M Joshua, et al.
Cancers|January 28, 2026
Nuclear Imaging in Renal Cell Carcinoma: Current Evidence and Clinical ApplicationsAbdullah Al-Khanaty, Shane Qin, Carlos Delgado, et al.
BJU International|November 12, 2013
The Melbourne Consensus Statement on the early detection of prostate cancerDeclan G Murphy, Thomas Ahlering, William J Catalona, et al.
European Urology Open Science|October 3, 2022
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell CarcinomaCristian Udovicich, Jason Callahan, Mathias Bressel, et al.
Pageof 42

Showing results (321-330 of 415) with videos related to

Sort By:
Pageof 42
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in the proPSMA StudyDavid C Chen, James P Buteau, Louise Emmett, et al.
The Medical Journal of Australia|June 4, 2013
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011Sue M Evans, Jeremy L Millar, Ian D Davis, et al.
BJU International|June 28, 2025
Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinomaMuhammad Ali, Mathias Bressel, David Chang, et al.
The International Journal of Neuropsychopharmacology|October 12, 2017
Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal SymptomsGemma Modinos, Fatma Simsek, Jamie Horder, et al.
European Urology|September 20, 2018
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical TrialShankar Siva, Mathias Bressel, Declan G Murphy, et al.
Social Cognitive and Affective Neuroscience|December 31, 2015
Heritability of the limbic networksSanja Budisavljevic, Jamie M Kawadler, Flavio Dell'Acqua, et al.
BJU International|March 8, 2021
UpFrontPSMA: a randomized phase 2 study of sequential <sup>177</sup> Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naïve prostate cancer (clinical trial protocol)Nattakorn Dhiantravan, Louise Emmett, Anthony M Joshua, et al.
Cancers|January 28, 2026
Nuclear Imaging in Renal Cell Carcinoma: Current Evidence and Clinical ApplicationsAbdullah Al-Khanaty, Shane Qin, Carlos Delgado, et al.
BJU International|November 12, 2013
The Melbourne Consensus Statement on the early detection of prostate cancerDeclan G Murphy, Thomas Ahlering, William J Catalona, et al.
European Urology Open Science|October 3, 2022
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell CarcinomaCristian Udovicich, Jason Callahan, Mathias Bressel, et al.
Pageof 42